EcoDrugPlus

Mitogen-Activated Protein Kinase Kinase Kinase 5

Ensembl ID : ENSLACG00000000172
Gene Symbol: MAP3K5
3 Cross references
203 Possible Orthologues:

Mitogen-Activated Protein Kinase Kinase Kinase 8

Ensembl ID : ENSLACG00000010936
Gene Symbol: MAP3K8
4 Cross references
200 Possible Orthologues:

Mitogen-Activated Protein Kinase Kinase Kinase 9

Ensembl ID : ENSLACG00000008405
Gene Symbol: MAP3K9
2 Cross references
195 Possible Orthologues:

Monoglyceride Lipase

Ensembl ID : ENSLACG00000011685
Gene Symbol: MGLL
4 Cross references
208 Possible Orthologues:

Myeloblastin-Like

Ensembl ID : ENSLACG00000012775
Gene Symbol: LOC102347764
3 Cross references
993 Possible Orthologues:

Natriuretic Peptide Receptor 1

Ensembl ID : ENSLACG00000005999
Gene Symbol: NPR1
2 Cross references
260 Possible Orthologues:

Natriuretic Peptide Receptor 3

Ensembl ID : ENSLACG00000006786
Gene Symbol: NPR3
2 Cross references
212 Possible Orthologues:

Neurogenic Locus Notch Homolog Protein 2

Ensembl ID : ENSLACG00000003294
Gene Symbol: LOC102366854
2 Cross references
198 Possible Orthologues:

Neurogenic Locus Notch Homolog Protein 3

Ensembl ID : ENSLACG00000000165
Gene Symbol: LOC102353790
3 Cross references
198 Possible Orthologues:

Neuropeptide Y Receptor Y2

Ensembl ID : ENSLACG00000009115
Gene Symbol: NPY2R
2 Cross references
246 Possible Orthologues:

Neuropeptide Y Receptor Y5

Ensembl ID : ENSLACG00000009344
Gene Symbol: NPY5R
4 Cross references
135 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 1

Ensembl ID : ENSLACG00000015751
Gene Symbol: NTRK1
4 Cross references
199 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).